RecruitingPhase 3NCT04965298

Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole

Studying Idiopathic pulmonary fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Norfolk and Norwich University Hospitals NHS Foundation Trust
Principal Investigator
Professor Andrew Wilson
Norfolk and Norwich University Hospitals NHS Foundation Trust
Intervention
Lansoprazole(drug)
Enrollment
298 enrolled
Eligibility
40 years · All sexes
Timeline
2021 – 2026

Study locations (20)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04965298 on ClinicalTrials.gov

Other trials for Idiopathic pulmonary fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic pulmonary fibrosis →

← Back to all trials